17.68
price down icon0.45%   -0.13
 
loading
Schlusskurs vom Vortag:
$17.81
Offen:
$17.57
24-Stunden-Volumen:
167.58K
Relative Volume:
0.32
Marktkapitalisierung:
$786.22M
Einnahmen:
$159.01M
Nettoeinkommen (Verlust:
$-21.72M
KGV:
-34.00
EPS:
-0.52
Netto-Cashflow:
$-20.63M
1W Leistung:
-5.69%
1M Leistung:
-11.39%
6M Leistung:
+25.39%
1J Leistung:
+127.02%
1-Tages-Spanne:
Value
$17.26
$17.94
1-Wochen-Bereich:
Value
$17.26
$19.33
52-Wochen-Spanne:
Value
$5.55
$21.00

Axogen Inc Stock (AXGN) Company Profile

Name
Firmenname
Axogen Inc
Name
Telefon
(386) 462-6817
Name
Adresse
13631 PROGRESS BLVD., ALACHUA, FL
Name
Mitarbeiter
452
Name
Twitter
@AxoGen
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
AXGN's Discussions on Twitter

Vergleichen Sie AXGN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
AXGN
Axogen Inc
17.73 786.22M 159.01M -21.72M -20.63M -0.52
Medical Devices icon
ABT
Abbott Laboratories
131.73 225.32B 41.95B 13.40B 6.35B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
100.70 149.74B 16.75B 1.85B 2.37B 1.25
Medical Devices icon
SYK
Stryker Corp
374.83 142.48B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
88.67 113.49B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
72.08 42.10B 5.72B 4.17B 259.90M 6.97

Axogen Inc Stock (AXGN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-17 Eingeleitet Lake Street Buy
2024-07-01 Eingeleitet Raymond James Outperform
2022-11-11 Fortgesetzt Jefferies Buy
2022-05-09 Hochstufung Canaccord Genuity Hold → Buy
2022-03-11 Fortgesetzt Cantor Fitzgerald Overweight
2020-10-23 Eingeleitet Guggenheim Buy
2020-06-16 Fortgesetzt Cantor Fitzgerald Overweight
2020-05-07 Herabstufung Canaccord Genuity Buy → Hold
2020-04-02 Herabstufung BTIG Research Buy → Neutral
2019-08-07 Herabstufung William Blair Outperform → Mkt Perform
2019-07-12 Eingeleitet Canaccord Genuity Buy
2018-03-02 Bestätigt Lake Street Buy
2018-01-05 Fortgesetzt Cantor Fitzgerald Overweight
2017-11-30 Eingeleitet Jefferies Buy
2017-11-21 Bestätigt Lake Street Buy
2017-07-31 Eingeleitet Leerink Partners Outperform
2017-06-30 Eingeleitet Cantor Fitzgerald Overweight
2017-03-06 Eingeleitet ROTH Capital Buy
2016-11-22 Hochstufung Lake Street Hold → Buy
2016-11-07 Bestätigt Wedbush Outperform
2016-11-03 Herabstufung Lake Street Buy → Hold
2016-08-04 Bestätigt Wedbush Outperform
2014-05-14 Eingeleitet Dawson James Buy
2013-10-31 Bestätigt Ladenburg Thalmann Buy
Alle ansehen

Axogen Inc Aktie (AXGN) Neueste Nachrichten

pulisher
Mar 29, 2025

(AXGN) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Mar 29, 2025
pulisher
Mar 26, 2025

Shareholders Should Be Pleased With Axogen, Inc.'s (NASDAQ:AXGN) Price - Simply Wall St

Mar 26, 2025
pulisher
Mar 26, 2025

PNC Financial Services Group Inc. Decreases Holdings in AxoGen, Inc. (NASDAQ:AXGN) - Defense World

Mar 26, 2025
pulisher
Mar 25, 2025

Axogen: LT Bullish, But Outcomes Weighted To Downside At This Point (NASDAQ:AXGN) - Seeking Alpha

Mar 25, 2025
pulisher
Mar 25, 2025

Charles Schwab Investment Management Inc. Has $6.87 Million Position in AxoGen, Inc. (NASDAQ:AXGN) - Defense World

Mar 25, 2025
pulisher
Mar 24, 2025

AxoGen appoints Rick Ditto as VP, global health economics, reimbursment & policy - TipRanks

Mar 24, 2025
pulisher
Mar 24, 2025

Axogen Announces Appointment of Rick Ditto as Vice - GlobeNewswire

Mar 24, 2025
pulisher
Mar 24, 2025

Axogen Announces Appointment of Rick Ditto as Vice President, Global Health Economics, Reimbursement & Policy, and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Mar 24, 2025
pulisher
Mar 22, 2025

Bank of New York Mellon Corp Trims Position in AxoGen, Inc. (NASDAQ:AXGN) - Defense World

Mar 22, 2025
pulisher
Mar 20, 2025

Axogen’s chief innovation officer sells $264,442 in shares - Investing.com India

Mar 20, 2025
pulisher
Mar 20, 2025

AxoGen, Inc. (NASDAQ:AXGN) Receives $20.75 Average Target Price from Brokerages - Defense World

Mar 20, 2025
pulisher
Mar 20, 2025

US Bancorp DE Makes New $30,000 Investment in AxoGen, Inc. (NASDAQ:AXGN) - Defense World

Mar 20, 2025
pulisher
Mar 19, 2025

Axogen’s chief innovation officer sells $264,442 in shares By Investing.com - Investing.com UK

Mar 19, 2025
pulisher
Mar 18, 2025

Lake Street Initiates Coverage of Axogen (LSE:0HKD) with Buy Recommendation - Nasdaq

Mar 18, 2025
pulisher
Mar 18, 2025

AxoGen (NASDAQ:AXGN) Now Covered by Lake Street Capital - Defense World

Mar 18, 2025
pulisher
Mar 17, 2025

Lake Street Initiates Coverage of Axogen (AXGN) with Buy Recommendation - Nasdaq

Mar 17, 2025
pulisher
Mar 17, 2025

This Blueprint Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Mar 17, 2025
pulisher
Mar 17, 2025

Lake Street starts AxoGen stock with Buy, sets $30 target By Investing.com - Investing.com Canada

Mar 17, 2025
pulisher
Mar 17, 2025

Axogen, Inc. (NASDAQ:AXGN) is a favorite amongst institutional investors who own 75% - Yahoo Finance UK

Mar 17, 2025
pulisher
Mar 17, 2025

Lake Street starts AxoGen stock with Buy, sets $30 target - Investing.com

Mar 17, 2025
pulisher
Mar 17, 2025

Lake Street Initiates Axogen at Buy With $30 Price Target -March 17, 2025 at 08:17 am EDT - Marketscreener.com

Mar 17, 2025
pulisher
Mar 12, 2025

AxoGen’s SWOT analysis: nerve repair innovator’s stock poised for growth By Investing.com - Investing.com Canada

Mar 12, 2025
pulisher
Mar 12, 2025

AxoGen’s SWOT analysis: nerve repair innovator’s stock poised for growth - Investing.com

Mar 12, 2025
pulisher
Mar 10, 2025

Cantor maintains AxoGen stock target at $24, bullish on growth plan - Investing.com Australia

Mar 10, 2025
pulisher
Mar 10, 2025

Cantor maintains AxoGen stock target at $24, bullish on growth plan By Investing.com - Investing.com South Africa

Mar 10, 2025
pulisher
Mar 08, 2025

(AXGN) Technical Data - Stock Traders Daily

Mar 08, 2025
pulisher
Mar 08, 2025

Principal Financial Group Inc. Boosts Stock Position in AxoGen, Inc. (NASDAQ:AXGN) - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

Cantor Fitzgerald Reaffirms “Overweight” Rating for AxoGen (NASDAQ:AXGN) - Defense World

Mar 07, 2025
pulisher
Mar 07, 2025

Rhumbline Advisers Has $960,000 Stake in AxoGen, Inc. (NASDAQ:AXGN) - Defense World

Mar 07, 2025
pulisher
Mar 05, 2025

Axogen director Amy McBride sells $100,100 in stock By Investing.com - Investing.com Canada

Mar 05, 2025
pulisher
Mar 05, 2025

Insider Sell: Amy Wendell Sells 5,000 Shares of Axogen Inc (AXGN) - GuruFocus.com

Mar 05, 2025
pulisher
Mar 05, 2025

Axogen director Amy McBride sells $100,100 in stock - Investing.com India

Mar 05, 2025
pulisher
Mar 05, 2025

Analyst Expectations For Axogen's Future - Nasdaq

Mar 05, 2025
pulisher
Mar 05, 2025

Cantor Fitzgerald maintains AxoGen stock overweight rating By Investing.com - Investing.com Australia

Mar 05, 2025
pulisher
Mar 05, 2025

AxoGen’s Strategic Growth and Market Positioning: Buy Rating Affirmed by Caitlin Cronin - TipRanks

Mar 05, 2025
pulisher
Mar 05, 2025

Cantor Fitzgerald maintains AxoGen stock overweight rating - Investing.com India

Mar 05, 2025
pulisher
Mar 05, 2025

Citizens JMP reiterates AxoGen stock with $26 target By Investing.com - Investing.com South Africa

Mar 05, 2025
pulisher
Mar 05, 2025

Citizens JMP reiterates AxoGen stock with $26 target - Investing.com

Mar 05, 2025
pulisher
Mar 05, 2025

14,285 Shares in AxoGen, Inc. (NASDAQ:AXGN) Bought by Y Intercept Hong Kong Ltd - Defense World

Mar 05, 2025
pulisher
Mar 05, 2025

AxoGen’s Strategic Market Positioning and Anticipated BLA Approval Drive Buy Rating - TipRanks

Mar 05, 2025
pulisher
Mar 04, 2025

AxoGen Unveils Strategic Priorities for 2025-2028 - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

AxoGen, Inc. (NASDAQ:AXGN) Shares Purchased by New York State Common Retirement Fund - Defense World

Mar 04, 2025
pulisher
Mar 02, 2025

Leerink Partnrs Estimates AxoGen FY2029 Earnings - Defense World

Mar 02, 2025
pulisher
Mar 02, 2025

Cantor Fitzgerald Decreases Earnings Estimates for AxoGen - Defense World

Mar 02, 2025
pulisher
Mar 01, 2025

FY2025 EPS Estimates for AxoGen Lowered by Cantor Fitzgerald - MarketBeat

Mar 01, 2025
pulisher
Feb 28, 2025

AxoGen (NASDAQ:AXGN) Posts Quarterly Earnings Results - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Canaccord Genuity Group Forecasts Strong Price Appreciation for AxoGen (NASDAQ:AXGN) Stock - Defense World

Feb 28, 2025
pulisher
Feb 27, 2025

Investor Network: AxoGen, Inc. to Host Earnings Call - ACCESS Newswire

Feb 27, 2025

Finanzdaten der Axogen Inc-Aktie (AXGN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
medical_devices STE
$227.62
price up icon 0.80%
medical_devices ZBH
$112.47
price up icon 0.09%
medical_devices PHG
$24.92
price down icon 1.17%
$67.12
price down icon 0.77%
$79.03
price down icon 0.72%
medical_devices EW
$72.21
price up icon 0.49%
Kapitalisierung:     |  Volumen (24h):